L. Roever-Borges, Resende Es
Aug 10, 2015
Journal of Cardiovascular Diseases and Diagnosis
The infarct size is an important marker for early and late mortality after acute myocardial infarction [1,2]. The metabolic syndrome (MetS) is interrelated atherosclerotic risk factors including insulin resistance, hypertension, a low level of high-density lipoprotein (HDL) cholesterol, a high triglyceride level, a high plasma glucose concentration, central obesity, and the increased number of components of the metabolic syndrome is associated with a higher mean carotid intima media thickness, lower ankle brachial pressure index in patients with coronary heart disease, peripheral arterial disease, or abdominal aortic aneurysm [3-5].